OTCM
KAST
Market cap23kUSD
Jul 09, Last price
0.57USD
1D
0.00%
1Q
-48.36%
Jan 2017
-99.94%
IPO
-98.11%
Name
Kasten Inc
Chart & Performance
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-20.25%
Rev. gr., 5y
%
Revenues
306k
+33.10%
Net income
-63k
L
CFO
533k
P
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Kasten, Inc., known commercially as DAKOTA Life Sciences, operates as a biopharmaceutical firm. Its primary endeavors involve obtaining, advancing, and bringing to market therapeutic agents crafted to avert and mitigate severe medical conditions prevalent in both hospital and general community environments. A significant aspect of its mission is to provide affordable and accessible pharmaceutical solutions, especially for individuals grappling with antimicrobial resistance. The company was founded in 1986 and is headquartered in Sioux Falls, South Dakota.
Valuation
Title in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT |